414 related articles for article (PubMed ID: 27541985)
21. Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons.
Garrido M; Tereshchenko Y; Zhevtsova Z; Taschenberger G; Bähr M; Kügler S
Acta Neuropathol; 2011 Apr; 121(4):475-85. PubMed ID: 21191602
[TBL] [Abstract][Full Text] [Related]
22. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
23. Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration.
Zharikov A; Bai Q; De Miranda BR; Van Laar A; Greenamyre JT; Burton EA
Neurobiol Dis; 2019 May; 125():146-153. PubMed ID: 30658149
[TBL] [Abstract][Full Text] [Related]
24. Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice.
Giaime E; Tong Y; Wagner LK; Yuan Y; Huang G; Shen J
Neuron; 2017 Nov; 96(4):796-807.e6. PubMed ID: 29056298
[TBL] [Abstract][Full Text] [Related]
25. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain.
Friedman LG; Lachenmayer ML; Wang J; He L; Poulose SM; Komatsu M; Holstein GR; Yue Z
J Neurosci; 2012 May; 32(22):7585-93. PubMed ID: 22649237
[TBL] [Abstract][Full Text] [Related]
26. Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer.
Zhou J; Yang J; Fan X; Hu S; Zhou F; Dong J; Zhang S; Shang Y; Jiang X; Guo H; Chen N; Xiao X; Sheng J; Wu K; Nie Y; Fan D
Autophagy; 2016; 12(3):515-28. PubMed ID: 26761524
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A.
Pajares M; Rojo AI; Arias E; Díaz-Carretero A; Cuervo AM; Cuadrado A
Autophagy; 2018; 14(8):1310-1322. PubMed ID: 29950142
[TBL] [Abstract][Full Text] [Related]
28. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.
St Martin JL; Klucken J; Outeiro TF; Nguyen P; Keller-McGandy C; Cantuti-Castelvetri I; Grammatopoulos TN; Standaert DG; Hyman BT; McLean PJ
J Neurochem; 2007 Mar; 100(6):1449-57. PubMed ID: 17241127
[TBL] [Abstract][Full Text] [Related]
30. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
31. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
Caudal D; Alvarsson A; Björklund A; Svenningsson P
Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
[TBL] [Abstract][Full Text] [Related]
33. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
34. Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles.
Löw K; Aebischer P; Schneider BL
Hum Gene Ther; 2013 Jun; 24(6):613-29. PubMed ID: 23600720
[TBL] [Abstract][Full Text] [Related]
35. Molecular control of chaperone-mediated autophagy.
Catarino S; Pereira P; Girão H
Essays Biochem; 2017 Dec; 61(6):663-674. PubMed ID: 29233876
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of LAMP2A by p38 MAPK couples ER stress to chaperone-mediated autophagy.
Li W; Zhu J; Dou J; She H; Tao K; Xu H; Yang Q; Mao Z
Nat Commun; 2017 Nov; 8(1):1763. PubMed ID: 29176575
[TBL] [Abstract][Full Text] [Related]
37. Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases.
Xilouri M; Stefanis L
Mol Cell Neurosci; 2015 May; 66(Pt A):29-36. PubMed ID: 25724482
[TBL] [Abstract][Full Text] [Related]
38. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy.
Ferreira JV; Fôfo H; Bejarano E; Bento CF; Ramalho JS; Girão H; Pereira P
Autophagy; 2013 Sep; 9(9):1349-66. PubMed ID: 23880665
[TBL] [Abstract][Full Text] [Related]
39. Regional deficiencies in chaperone-mediated autophagy underlie α-synuclein aggregation and neurodegeneration.
Malkus KA; Ischiropoulos H
Neurobiol Dis; 2012 Jun; 46(3):732-44. PubMed ID: 22426402
[TBL] [Abstract][Full Text] [Related]
40. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure.
Sun L; Lian Y; Ding J; Meng Y; Li C; Chen L; Qiu P
Brain Behav; 2019 Aug; 9(8):e01352. PubMed ID: 31286692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
